Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.

Kirkton RD, Santiago-Maysonet M, Lawson JH, Tente WE, Dahl SLM, Niklason LE, Prichard HL.

Sci Transl Med. 2019 Mar 27;11(485). pii: eaau6934. doi: 10.1126/scitranslmed.aau6934.

PMID:
30918113
2.

What is the greatest regulatory challenge in the translation of biomaterials to the clinic?

Prestwich GD, Bhatia S, Breuer CK, Dahl SL, Mason C, McFarland R, McQuillan DJ, Sackner-Bernstein J, Schox J, Tente WE, Trounson A.

Sci Transl Med. 2012 Nov 14;4(160):160cm14. doi: 10.1126/scitranslmed.3004915.

PMID:
23152323
3.

Readily available tissue-engineered vascular grafts.

Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE.

Sci Transl Med. 2011 Feb 2;3(68):68ra9. doi: 10.1126/scitranslmed.3001426.

4.

Lack of impact of rapid identification of rotavirus-infected patients on nosocomial rotavirus infections.

Dennehy PH, Tente WE, Fisher DJ, Veloudis BA, Peter G.

Pediatr Infect Dis J. 1989 May;8(5):290-6. Review.

PMID:
2657618
5.

Comparison of nine commercial immunoassays for the detection of rotavirus in fecal specimens.

Dennehy PH, Gauntlett DR, Tente WE.

J Clin Microbiol. 1988 Sep;26(9):1630-4.

Supplemental Content

Loading ...
Support Center